# Endo Assess Cgm Components Knowledge

> Assesses patient's ability to identify the receiver, sensor, and transmitter components of a real-time CGM system. Triggered by clinician requests to review CGM parts or verify patient can name sensor, transmitter, and receiver.

- Skill: `dromlakhani/endo-assess-cgm-components-knowledge` (Agent Skill)
- Install (CLI): `npx skillmds@latest add dromlakhani/endo-assess-cgm-components-knowledge`
- Raw SKILL.md: https://api.skillmd.com/api/skills/dromlakhani/endo-assess-cgm-components-knowledge/raw
- Safety review: pending (external: skill-scanner PASS, skillspector PASS)
- Works with: Claude Code, Claude.ai, OpenAI Codex
- Category: Coding & Dev Tools
- Author: dromlakhani (https://skillmd.com/u/dromlakhani)
- Updated: 2026-09-08
- Page: https://skillmd.com/skills/dromlakhani/endo-assess-cgm-components-knowledge

---


# Assess knowledge of CGM system components

## STEP 1 — Gather Information
Ask the patient to name the three main components of their CGM system (receiver, sensor, transmitter) or point to each part on the device or packaging.

## STEP 2 — Rule In / Rule Out
Does the patient correctly name all three components? If yes → adequate knowledge; if no → insufficient knowledge.

## STEP 3 — Classify or Stratify
Classify knowledge level: 3/3 correct (adequate), 2/3 correct (partial), 0-1/3 correct (poor).

## STEP 4 — Decide
If adequate knowledge, proceed with CGM initiation or advanced training; if partial or poor, provide targeted education on the missing component(s) and reassess.

## Clinical Guardrails / Mimics / Pitfalls
Do not assume prior CGM use guarantees component knowledge; avoid confusing transmitter (electronics) with sensor (subcutaneous filament); consider visual or cognitive impairments that may affect identification.

## Concrete Clinical Example
A 58‑year‑old with type 1 diabetes starting a Dexcom G6 is asked to name the CGM parts; they correctly identify the sensor and receiver but call the transmitter the “battery.” Educator clarifies the transmitter’s role and reassesses, after which the patient names all three correctly.

**Source:** Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI: 10.1210/jc.2016-2534